Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled trial of teriflunomide sodium tablets in systemic lupus erythematosus
CTR20180837Phase 2Completed
- Sponsor
- 苏州长征-欣凯制药
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of teriflunomide in systemic lupus erythematosus (SLE), sponsored by 苏州长征-欣凯制药. Started May 2019; status: completed.
02
Drugs
teriflunomide
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on CTR20180837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180837.